secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncology Institute, Inc. (TOI)
CIK:        0001799191
Form:       8-K
Filed at:   2023-05-22T23:59:59+00:00
Accession:  0001799191-23-000006
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

COO Matthew Miller to depart June 16, 2023; duties assumed by President Virnich
-------------------------------------------------------------------------------

- Dr. Matthew Miller terminated as COO effective June 16, 2023; severance includes 3 months base salary and healthcare.
- Option exercise period extended to May 18, 2024, contingent on signing a general release of claims.
- No replacement will be hired; President Dr. Daniel Virnich will absorb COO responsibilities.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799191/000179919123000006/0001799191-23-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799191/000179919123000006/toi-20230518.htm
  HTML page:      https://secwatch.observer/filing/0001799191-23-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer